189 related articles for article (PubMed ID: 37994745)
21. Data analysis methods for defining biomarkers from omics data.
Li C; Gao Z; Su B; Xu G; Lin X
Anal Bioanal Chem; 2022 Jan; 414(1):235-250. PubMed ID: 34951658
[TBL] [Abstract][Full Text] [Related]
22. Cancer biomarker discovery and translation: proteomics and beyond.
Hristova VA; Chan DW
Expert Rev Proteomics; 2019 Feb; 16(2):93-103. PubMed ID: 30556752
[TBL] [Abstract][Full Text] [Related]
23. Omics for the future in asthma.
Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
[TBL] [Abstract][Full Text] [Related]
24. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.
La Cognata V; Morello G; Cavallaro S
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062930
[TBL] [Abstract][Full Text] [Related]
25. The Omics Revolution Continues: The Maturation of High-Throughput Biological Data Sources.
Mathé E; Hays JL; Stover DG; Chen JL
Yearb Med Inform; 2018 Aug; 27(1):211-222. PubMed ID: 30157526
[TBL] [Abstract][Full Text] [Related]
26. Omics technologies in personalized combination therapy for cardiovascular diseases: challenges and opportunities.
Banerjee S; Prabhu Basrur N; Rai PS
Per Med; 2021 Sep; 18(6):595-611. PubMed ID: 34689602
[TBL] [Abstract][Full Text] [Related]
27. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome.
Romero R; Espinoza J; Gotsch F; Kusanovic JP; Friel LA; Erez O; Mazaki-Tovi S; Than NG; Hassan S; Tromp G
BJOG; 2006 Dec; 113 Suppl 3(Suppl 3):118-35. PubMed ID: 17206980
[TBL] [Abstract][Full Text] [Related]
28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
29. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.
Umelo IA; Costanza B; Castronovo V
Cancer Metastasis Rev; 2018 Mar; 37(1):125-145. PubMed ID: 29392535
[TBL] [Abstract][Full Text] [Related]
30. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
31. Omics phenotyping in heart failure: the next frontier.
Bayes-Genis A; Liu PP; Lanfear DE; de Boer RA; González A; Thum T; Emdin M; Januzzi JL
Eur Heart J; 2020 Sep; 41(36):3477-3484. PubMed ID: 32337540
[TBL] [Abstract][Full Text] [Related]
32. Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment.
Pinker K; Chin J; Melsaether AN; Morris EA; Moy L
Radiology; 2018 Jun; 287(3):732-747. PubMed ID: 29782246
[TBL] [Abstract][Full Text] [Related]
33. Patient-specific multi-omics models and the application in personalized combination therapy.
John A; Qin B; Kalari KR; Wang L; Yu J
Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
[TBL] [Abstract][Full Text] [Related]
34. Integrative omics for health and disease.
Karczewski KJ; Snyder MP
Nat Rev Genet; 2018 May; 19(5):299-310. PubMed ID: 29479082
[TBL] [Abstract][Full Text] [Related]
35. The systems medicine of neonatal abstinence syndrome.
Stone WL; Wood DL; Justice NA; Shah DS; Olsen ME; Bharti D
Front Biosci (Landmark Ed); 2020 Jan; 25(4):736-759. PubMed ID: 31585915
[TBL] [Abstract][Full Text] [Related]
36. "Omics" in oral cancer: New approaches for biomarker discovery.
Rai V; Mukherjee R; Ghosh AK; Routray A; Chakraborty C
Arch Oral Biol; 2018 Mar; 87():15-34. PubMed ID: 29247855
[TBL] [Abstract][Full Text] [Related]
37. From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms.
Redenšek S; Dolžan V; Kunej T
OMICS; 2018 Jan; 22(1):1-16. PubMed ID: 29356624
[TBL] [Abstract][Full Text] [Related]
38. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
39. Omics technologies in allergy and asthma research: An EAACI position paper.
Radzikowska U; Baerenfaller K; Cornejo-Garcia JA; Karaaslan C; Barletta E; Sarac BE; Zhakparov D; Villaseñor A; Eguiluz-Gracia I; Mayorga C; Sokolowska M; Barbas C; Barber D; Ollert M; Chivato T; Agache I; Escribese MM
Allergy; 2022 Oct; 77(10):2888-2908. PubMed ID: 35713644
[TBL] [Abstract][Full Text] [Related]
40. Utilising the precision nutrition toolkit in the path towards precision medicine.
Sawicki C; Haslam D; Bhupathiraju S
Proc Nutr Soc; 2023 Sep; 82(3):359-369. PubMed ID: 37475596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
